Background Multiple vaccine candidates against COVID-19 are currently being evaluated.
We evaluate the safety and immunogenicity protein of a novel SARS-CoV-2 virus receptor-…

Background COVID-19 vaccines have proven safe and efficacious in reducing severe
illness and death. Cuban protein subunit vaccine Abdala has shown safety, tolerability and …

Background The pandemic of COVID-19 raised the urgent need for safe and efficacious
vaccines against SARS-CoV-2. We evaluated the efficacy and safety of a new SARS-CoV-2 …

Manufactures of biotechnological/biological products (including vaccines) frequently make
changes to manufacturing processes of products both during development and after approval…

Abstract Objectives: IFN-alpha2b and IFN-gamma combination has demonstrated favorable
pharmacodynamics for genes underlying antiviral activity which might be involved in the …

Background COVID-19 in paediatric ages could result in hospitalizations and death. In
addition, excluding children from vaccination could turn them into reservoirs of the SARS-COV-2. …

A post-marketing, double blind, randomised, controlled clinical trial to assess the immunogenicity
and safety profiles of four commercially available recombinant hepatitis B vaccines …

Objective This study tested the hypothesis that a neuroprotective combined therapy based on
epidermal growth factor (EGF) and growth hormone-releasing hexapeptide (GHRP6) could …

The convergence of life sciences with neurosciences, nanotechnology, data management,
and engineering has caused a technological diversification of the biotechnology, …

The combined HB-Hib vaccine candidate Hebervac HB-Hib® (CIGB, La Habana), comprising
recombinant HBsAg and tetanus toxoid conjugate synthetic PRP antigens has shown to be …